Economies of scale in institutional review boards

Medical Care

Volumn 42, Issue 8, 2004, Pages 817-823

  Wagner, Todd H ^a,d   Cruz, Anne Marie E ^b   Chadwick, Gary L ^c  

^a STANFORD UNIVERSITY   (United States)

^b KAISER PERMANENTE   (United States)

^c UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^d NONE   (United States)

Author keywords

Bioethics; Costs; Economics; Review committees

Indexed keywords

ARTICLE; BIOMEDICAL AND BEHAVIORAL RESEARCH; CLINICAL PROTOCOL; CROSS-SECTIONAL STUDY; ECONOMICS; EMPIRICAL APPROACH; ETHICS; FINANCIAL MANAGEMENT; GOVERNMENT; HOSPITAL COST; HUMAN; HUMAN EXPERIMENT; INFORMATION PROCESSING; INSTITUTIONAL ETHICS; INVESTMENT; PROFESSIONAL STANDARD; PUBLIC HOSPITAL; REGRESSION ANALYSIS; STANDARD; STATISTICS; UNITED STATES; WORKLOAD;

BIOMEDICAL AND BEHAVIORAL RESEARCH; EMPIRICAL APPROACH;

CLINICAL PROTOCOLS; CROSS-SECTIONAL STUDIES; DATA COLLECTION; ETHICS COMMITTEES, RESEARCH; ETHICS, INSTITUTIONAL; FINANCIAL SUPPORT; HOSPITAL COSTS; HOSPITALS, VETERANS; HUMAN EXPERIMENTATION; HUMANS; INVESTMENTS; REGRESSION ANALYSIS; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS; WORKLOAD;

EID: 4043073613     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlr.0000132395.32967.d4     Document Type: Article

References (35)

1. Slater EE. IRS reform. N Engl J Med. 2002;346:1402-1404.
2. Institutional Review Boards: A Time for Reform. Rockville, MD: Office of the Inspector General, Department of Health and Human Services; 1998. OEI-01-97-00193.
3. Woodward B. Challenges to human subjects protections in US medical research. JAMA. 1999;282:1947-1952.
4. Protecting Human Research Subjects. Boston: Office of Inspector General, Department of Health and Human Services; 2000. OEI-01-97-00197.
5. Shalala D. Protecting research subjects-what must be done. N Engl J Med. 2000;343:808-810.
6. Burman WJ, Reves RR, Cohn DL, et al. Breaking the camel's back: multicenter clinical trials and local institutional review boards. Ann Intern Med. 2001;134:152-157.
7. Sugarman J. The role of institutional support in protecting human research subjects. Acad Med. 2000;75:687-692.
8. Schulman KA, Seils DM, Timbie JW, et al. A national survey of provisions in clinical-trial agreements between medical schools and industry sponsors. W Engl J Med. 2002;347:1335-1341.
9. Boyd EA, Bero LA. Assessing faculty financial relationships with industry: A case study. JAMA. 2000;284:2209-2214.
10. Lavori PW, Sugarman J, Hays MT, et al. Improving informed consent in clinical trials: a duty to experiment. Control Clin Trials. 1999;20:187-193.
11. Feussner JR, Burris JF, McGlynn G, et al. Enhancing protections for human participants in clinical and health services research: a continuing process. Med Care. 2002;40(suppl):V4-11.
12. Wood A, Grady C, Emanuel EJ. The Crisis in Human Participants Research: Identifying the Problems and Proposing Solutions. Bethesda, MD: National Institutes of Health, Department of Clinical Bioethics; 2002.
13. Fletcher JC, Hoffmann DE. Ethics committees: time to experiment with standards. Ann Intern Med. 1994;120:335-338.
14. Lin M, Miller J. Office for Protection From Research Risks (OPRR) Reports, Subject: Local IRB Review of Multicenter Clinical Trials. Bethesda: OPRR, National Institutes of Health; 1992. No. 93-01.
15. Puglisi JT, Ellis G, Lin M, et al. IRB Knowledge of Local Research Context. Rockville, MD: Department of Health and Human Services; August 27, 1998 [updated July 21, 2000].
16. Moreno J, Caplan A, Wolpe P, and the members of the Project on Informed Consent. Updating protections for human subjects involved in research. JAMA. 1998;280:1951-1958.
17. Wagner TH, Bhandari A, Chadwick GL, et al. The cost of operating institutional review boards (IRBs). Acad Med. 2003;78:638-644.
18. General Accounting Office. VA Research: System for Protecting Human Subjects Needs Improvements. Washinaton, DC; 2000. GAO/T-HEHS-00-203.
19. Officefinder. Tenants rules of thumb. Available at: http://www.office- finder.com/how.html. Accessed October 11, 2001.
20. Oncor International. Available at: http://www.oncorintl.com. Accessed October 11, 2001.
21. Fare R, Grosskopf S, Lovell CAK. The Measurement of Efficiency of Production (Studies in Productivity Analvsis, No. 6). Hincham, MA: Kluwer; 1985.
22. Duan N. Smearing estimate: a nonparametric retransformation method. JASA. 1983;78:605-610.
23. Ai C, Norton EC. Standard errors for the retransformation problem with heteroscedasticity. J Health Econ. 2000;19:697-718.
24. Gertler PJ, Waldman DM. Quality-adjusted cost functions and policy evaluation in the nursing home industry. Journal of Political Economy. 1992;100:1232-1256.
25. Evaluation of NIH Implementation of Section 491 of the Public Health Service Act, Mandating a Program of Protection for Research Subjects. Arlington, VA: James Bell & Associates; 1998.
26. Ramsey J. Tests for specification errors in classical linear least squares regression analysis. JR Stat Soc. 1969;Series B:350-371.
27. Luft HS, Hunt SS, Maerki SC. The volume-outcome relationship: practice-makes-perfect or selective-referral patterns? Health Serv Res. 1987;22:157-182.
28. Health Insurance Portability and Accountability Act of 1996. Pub. L. No. 104-191, 110 Stat. 1936; 1996.
29. Annas GJ. HIPAA regulations - a new era of medical-record privacy? N Engl J Med. 2003;348:1486-1490.
30. Kilbridge P. The cost of HIPAA compliance. N Engl J Med. 2003;348:1423-1424.
31. Varmus HE, Friedman MA. Final Report on Low-Volume Institutional Review Boards. Bethesda, MD: National Institutes of Health and Food and Drug Administration; 1998. OEI-01-97-00194.
32. Rosenzweig RM. The politics of indirect costs. Council on Governmental Relations. Available at: http://www.cogr.edu/Rosenzweig.htm. Accessed June 5, 2002.
33. National Commission for the Protection of Human Subjects of Biomedical Research. Report and Recommendations: Institutional Review Boards. Washington, DC: DHEW; 1978.
34. Ethical and Policy Issues in Research Involving Human Participants. Bethesda, MD: National Bioethics Advisory Commission; December 19, 2000.
35. Gold MR, Siegel JE, Russell LB, et al., eds. Cost-effectiveness in Health and Medicine. Oxford: Oxford University Press; 1996.